Clover Health Investments Corp (NASDAQ:CLOV) price on current trading day, fall -2.62% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $3.71.
A look at the stock’s price movement, the close in the last trading session was $3.81, moving within a range at $3.65 and $3.8053. The beta value (5-Year monthly) was 2.011. Turning to its 52-week performance, $4.87 and $0.61 were the 52-week high and 52-week low respectively. Overall, CLOV moved -15.87% over the past month.
Clover Health Investments Corp’s market cap currently stands at around $1.90 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Analysts have a consensus estimate of 466.93M for the company’s revenue for the quarter, with a low and high estimate of 460.57M and 476.9M respectively. The average forecast suggests up to a 34.59% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 1.86B, representing a 36.00% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CLOV is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 0 recommend CLOV as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CLOV’s current price about -3.67% and -9.45% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 45.02, while 7-day volatility ratio is 6.07% and 7.81% in the 30-day chart. Further, Clover Health Investments Corp (CLOV) has a beta value of 1.97, and an average true range (ATR) of 0.27. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -61.73% off current price level while to achieve the yearly target high, price needs to move -61.73%. Nonetheless, investors will most likely welcome a -61.73% jump to $6 which is the analysts’ median price.
If we refocus on Clover Health Investments Corp (NASDAQ:CLOV), historical trading data shows that trading volumes averaged 6.78 over the past 10 days and 6.16 million over the past 3 months. The company’s latest data on shares outstanding shows there are 395.74 million shares.
The 25.08% of Clover Health Investments Corp’s shares are in the hands of company insiders while institutional holders own 18.20% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.9 million on 2025-02-28, giving us a short ratio of 2.24. The data shows that as of 2025-02-28 short interest in Clover Health Investments Corp (CLOV) stood at 288.00001 of shares outstanding, with shares short falling to 15.08 million registered in 2025-01-31. Current price change has pushed the stock 17.78% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CLOV stock continues to rise going into the next quarter.
